Advertisement
Home Tags Vaginal Problems

Tag: Vaginal Problems

The U.S. Preventive Services Task Force recommends against screening for bacterial vaginosis in pregnant women not at increased preterm delivery risk

USPSTF Against Bacterial Vaginosis Screening to Prevent Preterm Delivery

Screening not advised for asymptomatic pregnant women not at increased risk for preterm delivery
For menopausal women with significant vaginal atrophy symptoms

Fractionated CO2 Laser Tx, Estrogen Similar for Menopause

Similar improvement seen in genitourinary syndrome of menopause symptoms, sexual function
The U.S. Preventive Services Task Force (USPSTF) recommends against screening for bacterial vaginosis in pregnant women who are not at increased risk for preterm delivery; for pregnant women at increased risk for preterm delivery

Screening for Bacterial Vaginosis in Pregnancy Not Advised

USPSTF finds no net benefit from screening among those not at increased risk for preterm delivery
Among women with symptomatic uterovaginal prolapse

Vaginal Mesh Hysteropexy No Better for Uterovaginal Prolapse

No significantly lower composite prolapse outcome found for vaginal hysteropexy versus vaginal hysterectomy
A 2011 U.S. Food and Drug Administration safety communication correlated with a significant decline in transvaginal mesh use for treatment of apical prolapse

2011 FDA Safety Message Tied to Drop in Transvaginal Mesh Use

Proportion of apical procedures using transvaginal mesh decreased in year after safety communication
The U.S. Food and Drug Administration on Tuesday announced a ban on the sale of all pelvic mesh products.

FDA Halts All Sales of Pelvic Mesh Products Tied to Injuries in Women

Remaining manufacturers have failed to prove the long-term safety or benefit of their devices
State lawsuits over pelvic mesh products could scare women away from the products or even get them removed from the market

Doctors Question State Lawsuits Over Pelvic Mesh Products

Lawsuits claim Johnson & Johnson did not fully disclose safety risks of transvaginal mesh products
For women with provoked vulvodynia

Gabapentin Improves Sexual Function in Provoked Vulvodynia

Sexual function improved for gabapentin vs. placebo, but still lower than among matched pain-free controls
For postmenopausal women

Postmenopausal Vaginal Estrogen Not Tied to Negative Health Outcomes

No difference in cardiovascular disease, cancer, hip fracture for users or nonusers of vaginal estrogen
After childbirth

Delivery Mode Tied to Pelvic Floor Disorder Risk Post-Childbirth

Larger genital hiatus tied to higher pelvic organ prolapse risk, regardless of delivery mode